{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:44:45Z","timestamp":1791967485691,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.tjog.2016.02.019","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T11:30:59Z","timestamp":1482924659000},"page":"791-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial"],"prefix":"10.1016","volume":"55","author":[{"given":"Essam Rashad","family":"Othman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret Fathy","family":"Fayez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaa Eldeen Mohamed Abd","family":"El Aal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem Saad","family":"El-Dine Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohammed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Khairy","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2016.02.019_bib1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(06)69522-6","article-title":"Oral misoprostol in preventing postpartum hemorrhage in resource\u2014poor communities: a randomized controlled trial","volume":"368","author":"Derman","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tjog.2016.02.019_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ics.2004.12.039","article-title":"Misoprostol in the management of postpartum hemorrhage","volume":"1279","author":"Feitsa","year":"2005","journal-title":"Int Congr Series"},{"key":"10.1016\/j.tjog.2016.02.019_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.lpm.2007.05.023","article-title":"Misoprostol for treating postpartum hemorrhage","volume":"37","author":"Godard","year":"2008","journal-title":"Press Med"},{"key":"10.1016\/j.tjog.2016.02.019_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1067\/mob.2001.117363","article-title":"A\u00a0randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage","volume":"185","author":"Jackson","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2016.02.019_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijgo.2006.05.031","article-title":"Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery","volume":"95","author":"Lapaire","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.tjog.2016.02.019_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ogc.2005.01.006","article-title":"Third stage of labor","volume":"32","author":"Magann","year":"2005","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.tjog.2016.02.019_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/01443610410001722509","article-title":"Massive postpartum hemorrhage as a cause of maternal morbidity in large tertiary hospital","volume":"24","author":"Hazra","year":"2004","journal-title":"J\u00a0Obstet Gynecol"},{"key":"10.1016\/j.tjog.2016.02.019_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0001-6349.2004.00572.x","article-title":"A\u00a0pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor","volume":"83","author":"Lam","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tjog.2016.02.019_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jmwh.2004.04.001","article-title":"Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings","volume":"49","author":"Miller","year":"2004","journal-title":"J\u00a0Midwifery Womens Health"},{"key":"10.1016\/j.tjog.2016.02.019_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.tjog.2016.02.019_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0020-7292(01)00498-2","article-title":"Misoprostol versus oxytocin in the third stage of labor","volume":"75","author":"Kundodyiwa","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.tjog.2016.02.019_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1447-0756.2005.00307.x","article-title":"Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage","volume":"31","author":"Ozkaya","year":"2005","journal-title":"J\u00a0Obstet Gynecol Res"},{"key":"10.1016\/j.tjog.2016.02.019_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1471-0528.2004.00103.x","article-title":"Successful reduction of massive postpartum hemorrhage by use of guidelines and staff education","volume":"111","author":"Rizvi","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.tjog.2016.02.019_bib14","first-page":"11","volume":"vol. 94","author":"World Health Organization","year":"1998"},{"key":"10.1016\/j.tjog.2016.02.019_bib15","article-title":"Advance misoprostol distribution for preventing and treating postpartum haemorrhage","volume":"2","author":"Oladapo","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tjog.2016.02.019_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijgo.2005.10.008","article-title":"Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section","volume":"92","author":"Vimala","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.tjog.2016.02.019_bib17","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1471-0528.2000.tb11109.x","article-title":"A\u00a0double-blind placebo controlled randomized trial of misoprostol and oxytocin in the management of the third stage of labor","volume":"107","author":"Walley","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.tjog.2016.02.019_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1034\/j.1600-0412.2001.080003245.x","article-title":"A\u00a0randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section","volume":"80","author":"Acharya","year":"2001","journal-title":"Acta Obstet Gynaecol Scand"},{"key":"10.1016\/j.tjog.2016.02.019_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijgo.2006.12.016","article-title":"Misoprostol versus oxytocin for the reduction of postpartum blood loss","volume":"97","author":"Baskett","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.tjog.2016.02.019_bib20","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1471-0528.2004.00217.x","article-title":"Misoprostol in the treatment of postpartum hemorrhage in addition to routine management: a placebo randomized controlled trial","volume":"111","author":"Walraven","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.tjog.2016.02.019_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.331.7519.723","article-title":"Effect of sublingual misoprostol on severe postpartum hemorrhage in a primary health centre in Guinea-Bissau: randomized double blind clinical trial","volume":"331","author":"Hoj","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.tjog.2016.02.019_bib22","first-page":"1341","article-title":"Reduced postpartum bleeding after treatment with sublingual misoprostol: a randomized double-blind clinical study in a developing country\u2014secondary publication","volume":"168","author":"Nielsen","year":"2006","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.tjog.2016.02.019_bib23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(01)05835-4","article-title":"WHO multicentre randomized trial of misoprostol in the management of the third stage of labor","volume":"358","author":"Gulmezoglu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.tjog.2016.02.019_bib24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1447-0756.2007.00661.x","article-title":"Oral misoprostol for the prevention of primary postpartum hemorrhage during third stage of labor","volume":"33","author":"Enakpene","year":"2007","journal-title":"J\u00a0Obstet Gynecol Res"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455916301887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455916301887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:48:19Z","timestamp":1791964099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455916301887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1028455916301887"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2016.02.019","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2016.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}